Literature DB >> 1946405

Isolation of a candidate repressor/activator, NF-E1 (YY-1, delta), that binds to the immunoglobulin kappa 3' enhancer and the immunoglobulin heavy-chain mu E1 site.

K Park1, M L Atchison.   

Abstract

We have determined that the developmental control of immunoglobulin kappa 3' enhancer (kappa E3') activity is the result of the combined influence of positive- and negative-acting elements. We show that a central core in the kappa E3' enhancer is active at the pre-B-cell stage but is repressed by flanking negative-acting elements. The negative-acting sequences repress enhancer activity in a position- and orientation-independent manner at the pre-B-cell stage. We have isolated a human cDNA clone encoding a zinc finger protein (NF-E1) that binds to the negative-acting segment of the kappa E3' enhancer. This protein also binds to the immunoglobulin heavy-chain enhancer mu E1 site. NF-E1 is encoded by the same gene as the YY-1 protein, which binds to the adeno-associated virus P5 promoter. NF-E1 is also the human homologue of the mouse delta protein, which binds to ribosomal protein gene promoters. The predicted amino acid sequence of this protein contains features characteristic of transcriptional activators as well as transcriptional repressors. Cotransfection studies with this cDNA indicate that it can repress basal promoter activity. The apparent dual function of this protein is discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1946405      PMCID: PMC52809          DOI: 10.1073/pnas.88.21.9804

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Delta, a transcription factor that binds to downstream elements in several polymerase II promoters, is a functionally versatile zinc finger protein.

Authors:  N Hariharan; D E Kelley; R P Perry
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

2.  Multiple nuclear factors interact with the immunoglobulin enhancer sequences.

Authors:  R Sen; D Baltimore
Journal:  Cell       Date:  1986-08-29       Impact factor: 41.582

3.  A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes.

Authors:  H Singh; R Sen; D Baltimore; P A Sharp
Journal:  Nature       Date:  1986 Jan 9-15       Impact factor: 49.962

4.  Immunoglobulin gene transcription is activated by downstream sequence elements.

Authors:  C Queen; D Baltimore
Journal:  Cell       Date:  1983-07       Impact factor: 41.582

5.  A lymphocyte-specific enhancer in the mouse immunoglobulin kappa gene.

Authors:  D Picard; W Schaffner
Journal:  Nature       Date:  1984 Jan 5-11       Impact factor: 49.962

6.  Cell-type specific expression of a transfected immunoglobulin gene.

Authors:  J Stafford; C Queen
Journal:  Nature       Date:  1983 Nov 3-9       Impact factor: 49.962

7.  Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs.

Authors:  M Kozak
Journal:  Nucleic Acids Res       Date:  1984-01-25       Impact factor: 16.971

8.  B lineage--specific interactions of an immunoglobulin enhancer with cellular factors in vivo.

Authors:  A Ephrussi; G M Church; S Tonegawa; W Gilbert
Journal:  Science       Date:  1985-01-11       Impact factor: 47.728

9.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

10.  Expression and regulation of Escherichia coli lacZ gene fusions in mammalian cells.

Authors:  C V Hall; P E Jacob; G M Ringold; F Lee
Journal:  J Mol Appl Genet       Date:  1983
View more
  143 in total

1.  BSAP can repress enhancer activity by targeting PU.1 function.

Authors:  S Maitra; M Atchison
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

2.  Differentiation-dependent mechanisms of transcriptional regulation of the catalytic subunit of phosphorylase kinase.

Authors:  Alison M O'Mahony; Donal A Walsh
Journal:  Biochem J       Date:  2002-02-15       Impact factor: 3.857

3.  The isolation of transcription factors from lambda gt11 cDNA expression libraries: human steroid 5 alpha-reductase 1 has sequence-specific DNA binding activity.

Authors:  K Gaston; M Fried
Journal:  Nucleic Acids Res       Date:  1992-12-11       Impact factor: 16.971

4.  Identification of regulatory elements within the minimal promoter region of the human endogenous ERV9 proviruses: accurate transcription initiation is controlled by an Inr-like element.

Authors:  G La Mantia; B Majello; A Di Cristofano; M Strazzullo; G Minchiotti; L Lania
Journal:  Nucleic Acids Res       Date:  1992-08-25       Impact factor: 16.971

5.  Activation of c-myc promoter P1 by immunoglobulin kappa gene enhancers in Burkitt lymphoma: functional characterization of the intron enhancer motifs kappaB, E box 1 and E box 2, and of the 3' enhancer motif PU.

Authors:  N E Wittekindt; K Hörtnagel; C Geltinger; A Polack
Journal:  Nucleic Acids Res       Date:  2000-02-01       Impact factor: 16.971

Review 6.  The basic RNA polymerase II transcriptional machinery.

Authors:  R Weinmann
Journal:  Gene Expr       Date:  1992

7.  RNA polymerase III dependence of the human L1 promoter and possible participation of the RNA polymerase II factor YY1 in the RNA polymerase III transcription system.

Authors:  K Kurose; K Hata; M Hattori; Y Sakaki
Journal:  Nucleic Acids Res       Date:  1995-09-25       Impact factor: 16.971

Review 8.  Regulation of serum amyloid A protein expression during the acute-phase response.

Authors:  L E Jensen; A S Whitehead
Journal:  Biochem J       Date:  1998-09-15       Impact factor: 3.857

9.  NF-HB (BSAP) is a repressor of the murine immunoglobulin heavy-chain 3' alpha enhancer at early stages of B-cell differentiation.

Authors:  M Singh; B K Birshtein
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

10.  A developmentally modulated chromatin structure at the mouse immunoglobulin kappa 3' enhancer.

Authors:  M C Roque; P A Smith; V C Blasquez
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.